Future Farm’s New LA Extraction Facility Sets a High Bar
Ryan Allway
August 9th, 2017
News, Top News
The cannabis industry is expected to reach $10 billion by 2018, according to Arcview Market Research, and extracts represent the fastest-growing segment. Concentrates account for between 30% and 60% of legal market sales and many experts believe those figures will only increase as users ditch cannabis flower and move toward purified extracts. These extracts are particularly helpful for pharmaceutical products incorporating cannabinoids.
In February, Future Farm Technologies Inc. (CSE: FFT) (OTCQB: FFRMF) entered into a management agreement with a Los Angeles, California-based non-profit that has a sublicense to legally manufacture cannabis oil using a non-volatile method. The company has made tremendous progress since the agreement in building out a state-of-the-art facility capable of producing high-quality, standardized, pharmaceutical-grade cannabis extracts as well as creating a pipeline of qualified sales leads which are being finalized.
“Professional extraction and refinement equipment and procedures enables us to ensure product purity, safety, and dosage control that promises to be the most valuable link in the supply chain for the future of the cannabis industry,” said Future Farm COO John Sweeney.
The patent-pending closed-loop liquid phase system uses falling film technology in a safe, non-pressurized design using alcohol as a solvent. Low temperatures and short residence times preserve all of the essential components of the cannabis plant, including cannabinoids, terpenes, and flavonoids. The company is currently is getting its trim supply from leading organic cannabis farmers to obtain the highest-quality starting ingredients for the oils.
According to the company’s investor presentation, the extraction technology is capable of processing 20 pounds of cannabis flower per hour with a 10% to 20% yield. An estimated wholesale price of $20.00 per gram means that the machine is capable of generating about $18,160 in revenue per hour. The company plans to execute sales agreements in 2017 as well as expand inventory and capacity ahead of California’s move to legalize recreational cannabis, which could create a $6.5 billion market in early 2018.
COO John Sweeney leads the team in Los Angeles with over 15 years of experience at pharmaceutical giants like Pfizer Inc. (NYSE: PFE) and Wyeth. With a focus on both leading technology and high-quality inputs, Mr. Sweeney and his team aim to produce the highest quality extracts by leveraging the company’s experience across several different industries, including lighting, vertical farming, and cultivation.
For more information, visit the company’s website at www.futurefarmtech.com or visit CannabisFN’s company profile.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Innovium is a global beverage and foods brands platform that builds on consumer market trends and takes them to scale.
MichiCann Medical Inc. owns or controls 11 medical cannabis dispensaries in Michigan and is in the final stages to acquire another 11 shops, as well as three indoor cultivation facilities in the state.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
